Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age

Usama Azhar

Status and phase: Unknown; Phase 4

Conditions: Allergic Rhinitis

Treatments: Drug: Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age

Study type: Interventional

Funder types: Other

Identifiers

NCT04957927

747/RC/KEMU

Details and patient eligibility

About

To determine the Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age.

Full description

Our study will compare the Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age as in our population compliance with oral medication is better among patients, and is socially and culturally more acceptable.

Enrollment: 60 estimated patients

Sex: All

Ages: 2 to 5 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age:02 to 05 Years of Age
• both genders will be included.
• patients diagnosed with allergic rhinitis.

Exclusion criteria

• patients older than 05 years of age
• a positive history of HIV,TB,Immune deficiency.
• any nasal structural abnormality i.e.polyps,deviated nasal septum.
• history of frequent nasal bleeding,epistaxis.
• concomitant asthma.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: Single Blind

---

60 participants in 2 patient groups

Intranasal Fluticasone Propionate Group

Experimental group

Description:

Intranasal Fluticasone Propionate 50mcg/actuation in each nostril 24 hourly

Treatment:

Drug: Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age

Montelukast Group

Experimental group

Description:

Montelukast 4mg oral granule formulation 24 hourly

Treatment:

Drug: Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age